Heregulin/β1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal- regulated kinase

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1620-1625

  Tan, Ming ^a   Grijalva, Rebecca ^a   Yu, Dihua ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; CARRIER PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GLYCOPROTEIN; HEREGULIN BETA1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; ONCOPROTEIN; PROTEIN KINASE (CALCIUM,CALMODULIN); TYROSINE;

ARTICLE; CELL ADHESION; CELL AGGREGATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; FEMALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CELL AGGREGATION; FEMALE; GLYCOPROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEUREGULIN-1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0033106477     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Kraus, M. H., Issing, W., Miki, T., Popescu, N. C., and Aaronson, S. A. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA, 86: 9193-9197, 1989.
2. erbB-4. Nature (Lond.), 366: 473-475, 1993.
3. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., Downward, J., Mayes, E. L. V., Whittle, N., Waterfeild, M. D., and Seeburg, P. H. Human EGF receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 418-425, 1984.
4. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor. Nature (Lond.), 319: 230-234, 1986.
5. Gullick, W. J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancer cells. Br. Med. Bull., 47: 87-98, 1991.
6. Hynes, N. E., and Stern, D. F. The biology of of erbB-2/neu/HER-2 and its role in cancer. Biochem. Biophys. Acta, 1198: 165-184, 1994.
7. erbB2. Science (Washington DC), 256: 1205-1210, 1992.
8. erbB2. Science (Washington DC), 249: 1552-1555, 1990.
9. Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S., Wen, D., Ogden, S. G., Ben Levy, R., and Yarden, Y. Isolation of the Neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell, 69: 205-216, 1992.
10. Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., Koski, R. A., Lu, H. S., and Yarden, Y. Neu differentiation factor, a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell, 69: 559-572, 1992.
11. King, C. R., Borrello, I., Bellot, F., Comoglio, P., and Schlessinger, J. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J., 7: 1647-1651, 1988.
12. Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., and Carraway, K. L. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 269: 14661-14665, 1994.
13. Bacus, S. S., Yarden, Y., Oren, M., Chin, D. M., Lyass, L., Zelnick, C. R., Kazarov, A., Toyofuku, W., Gray-Bablin, J., Beerli, R. R., Hynes, N. E., Nikiforov, M., Haffner, R., Gudkov, A., and Keyomarsi, K. Neu differentiation factor (heregulin) activates a p53-dependent pathway in cancer cells. Oncogene, 12: 2535-2547, 1996.
14. Carraway, K. L., Soltoff, S. P., and Cantley, L. C. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J. Biol. Chem., 270: 7111-7116, 1995.
15. Grasso, A. W., Wen, D., Miller, C. M., Rhim, J. S., Pretlow, T. G., and Kung, H. J. ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene, 15: 2705-2716, 1997.
16. Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Seger, R., Hynes, N. E., and Yarden, Y. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15: 254-264, 1996.
17. Marte, B. M., Jeschke, M., Graus-Porta, D., Taverna, D., Hofer, P., Groner, B., Yarden, Y., and Hynes, N. E. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Mol. Endocrinol., 9: 14-23, 1995.
18. Daly, J. M., Jannot, C. B., Beerli, R. R., Graus-Porta, D., Maurer, F. G., and Hynes, N. E. Neu differentiation factor induces erbB2 down-regulation and apoptosis of erbB-2-overexpressing breast tumor cells. Cancer Res., 57: 3804-3811, 1997.
19. Bacus, S. S., Gudkov, A. V., Zelnick, C. R., Chin, D., Stern, R., Stancovski, I., Peles, E., Ben-Baruch, N., Farbstein, H., Lupu, R., Wen, D., Sela, M., and Yarden, Y. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res., 53: 5251-5261, 1993.
20. Staebler, A., Sommers, C., Mueller, S., Bayers, S., Thompson, E. W., and Lupu, R. Modulation of breast cancer progression and differentiation by the erbB-2 ligand (gp30). Breast Cancer Res. Treat., 31: 175-182, 1994.
21. Adams, J. C. Cell adhesion-spreading frontiers, intricate insights. Trends Cell Biol., 7: 107-110, 1997.
22. Gumbiner, B. M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell, 84: 345-357, 1996.
23. Royal, L. and Park, M. Hepatocyte growth factor-induced scatter of madin-darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem., 270: 27780-27787, 1995.
24. Guyton, K. Z., Gorospe, M., Kensler, T. W., and Holbrook, N. J. Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion. Cancer Res., 56: 3480-3485, 1996.
25. Xu, F-J., Stack, S., Boyer, C., O'Briant, K., Yu, Y. H., and Bast, R. C. Heregulin and agonistic anti-pi 85(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis. Clin. Cancer Res., 3: 1629-1634, 1997.
26. Behrens, J., Mareel, M. M., Roy, F. M. V., and Birchmeier, W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol., 108: 2435-2447, 1989.
27. Vleminck, X. K., Vakaet, J. L., Mareel, M., Fiers, W., and Roy, F. M. V. Genetic manipulation of E-cadherin expression by epithelial tumor cell reveals an invasion suppressor role. Cell, 66: 107-119, 1991.
28. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D., and Birchmeier, W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
29. Chen, H. C., and Guan, J. L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA, 91: 10148-10152, 1994.
30. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270: 27489-27494, 1995.
31. Dudley, D. T., Pang, L., Decker, S. J., Bndges, A. J., and Saltiel, A. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA, 92: 7686-7689, 1995.
32. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., and Ui, M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem., 269: 3568-3573, 1994.
33. Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A., Abraham, R., Ashendel, C., Zalkow, L., Matter, W. F., Dodge, J., Grindey, G., and Vlahos, C. J. Wortmannin, a potent and selective inhibitor of phosphatidylinositol 3-kinase. Cancer Res., 54: 2419-2423, 1994.
34. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-Morpholinyl)-8-phenyl-4H-1benzopyran-4-one (LY294002). J. Biol. Chem., 269: 5241-5248, 1994.
35. Fedi, P., Pierce, J. H., Di Fiore, P. P., and Kraus, M. H. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cγ or GTPase-activating protein, distinguishes erbB-3 signaling from that of other ErbB/EGFR family members. Mol. Cell. Biol., 14: 492-500, 1994.
36. Escobedo, J. A., Kaplan, D. R., Kavanaugh, W. M., Turck, C. W., and Williams, L. T. A phosphatidylinositol 3-kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol. Cell. Biol., 11: 1125-1132, 1991.
37. McGlade, C. J., Ellis, C., Reedijk, M., Anderson, D., Mbamalu, G., Reith, A. D., Panayotou, G., End, P., Bernstein, A., and Kazlauskas, A. E. A. SH2 domains of the p85 α subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors. Mol. Cell. Biol., 12: 991-997, 1992.
38. Danilenko, D. M., Ring, B. D., Lu, J. Z., Tarpley, J. E., Chang, D., Liu, N., Wen, D., and Pierce, G. F. Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds. J. Clin. Invest., 95: 842-851, 1995.
39. Shaw, L. M., Rabinovitz, I., Wang, H. H. F., Toker, A., and Mercuric, A. M. Activatin of Phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell, 91: 949-960, 1997.
40. Frisch, S. M., and Dolter, K. E. Adenovirus E1a-mediated tumor suppression by a c-erbB-2/neu-independent mechanism. Cancer Res., 55: 5551-5555, 1995.
41. Wennstrom, S., Siegbahn, A., Yokote, K., Arvidsson, A-K., Heldin, C-H., Mori, S., and Claesson-Welsh, L. Membrane ruffling and chemotaxis transduced by the PDGF β-receptor require the binding site for phosphatidylinositol 3-kinase. Oncogene, 9: 651-660, 1994.
42. Hordijk, P. L., ten Klooster, J. P., van der Kammen, R. A., Michiels, F., Oomen, L. C. J. M., and Collard, J. G. Inhibition of invasion of epithelial cells by tiam 1-rac signaling. Science (Washington DC), 278: 1464-1466, 1997.
43. Glinsky, G. V. Cell adhesion and metastasis: is the site specificity of cancer metastasis determined by leukocyte-endothelial cell recognition and adhesion? Crit. Rev. Oncol. Hematol., 14: 229-278, 1993.
44. Raz, A. A. L., R. Endogenous-galactoside binding leclins; a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev., 6: 433-452, 1987.
45. Fidler, I. J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur. J. of Cancer, 9: 223-227, 1973.
46. Raz, A., Bucana, C., McLellan, W., and Fidler, I. J. Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonizing potential. Nature (Lond.), 284: 363-264, 1980.
47. Lotan, R., and Raz, A. Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation. Cancer Res., 43: 2088-2093, 1983.